Cg oncology to present at the td cowen 45th annual health care conference

Irvine, calif., feb. 26, 2025 (globe newswire) -- cg oncology, inc. (nasdaq: cgon), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer, today announced that arthur kuan, chairman & chief executive officer, is scheduled to present at the td cowen 45th annual health care conference in boston, ma on wednesday, march 5, 2025, at 11:10 am et.
COWN Ratings Summary
COWN Quant Ranking